Publication|Videos|November 14, 2023
Ashland Launches Viatel™ Ultrapure Bioresorbable Polymers for LAIIs
Author(s)Ashland
Dr Seán McMahon explains how Ashland’s Viatel™ bioresorbable work and rationalizes why formulators should consider using in the development of long acting injectables and implants.
Ashland has launched Viatel™ ultrapure bioresorbable polymers (lactide / glycolide / caprolactone chemistries), a higher purity platform of controlled release polymers used in long acting injectables and implants (LAII). Ultrapure provides improved release consistency, extended-release durations and are better suited for sensitive drug compounds due to the less acidic micro-environment.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
2
Women in STEM: Early Phase Drug Development
3
Rare Disease Treatments: Navigating the Economics of Global Innovation
4
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
5